| Primary |
| Contraception |
67.8% |
| Off Label Use |
5.5% |
| Menstrual Discomfort |
5.4% |
| Hypertension |
3.2% |
| Depression |
2.9% |
| Asthma |
2.4% |
| Endometriosis |
2.1% |
| Anxiety |
1.4% |
| Hormone Replacement Therapy |
1.1% |
| Menorrhagia |
1.1% |
| Diabetes Mellitus |
1.0% |
| Dysmenorrhoea |
1.0% |
| Anaemia |
0.8% |
| Menopause |
0.8% |
| Menstruation Irregular |
0.8% |
| Bipolar Disorder |
0.6% |
| Migraine |
0.6% |
| Uterine Haemorrhage |
0.6% |
| Fibromyalgia |
0.5% |
| Pain |
0.5% |
|
| Weight Increased |
21.1% |
| Unintended Pregnancy |
20.3% |
| Metrorrhagia |
11.5% |
| Menorrhagia |
5.4% |
| Amenorrhoea |
4.5% |
| Osteopenia |
4.2% |
| Vaginal Haemorrhage |
3.7% |
| Injection Site Pain |
2.8% |
| Injection Site Reaction |
2.8% |
| Menometrorrhagia |
2.8% |
| Vomiting |
2.8% |
| Osteoporosis |
2.3% |
| Pain |
2.3% |
| Rash |
2.3% |
| Weight Decreased |
2.3% |
| Headache |
2.0% |
| Urticaria |
2.0% |
| Alopecia |
1.7% |
| Infertility Female |
1.7% |
| Menstruation Irregular |
1.7% |
|
| Secondary |
| Contraception |
48.1% |
| Off Label Use |
9.2% |
| Menstrual Discomfort |
9.0% |
| Hypertension |
5.8% |
| Depression |
4.7% |
| Diabetes Mellitus |
2.9% |
| Menopause |
2.9% |
| Hormone Replacement Therapy |
2.5% |
| Convulsion |
2.2% |
| Menopausal Symptoms |
1.6% |
| Dysmenorrhoea |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Pelvic Pain |
1.3% |
| Menstruation Irregular |
1.1% |
| Premenstrual Syndrome |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Asthma |
0.9% |
| Menorrhagia |
0.9% |
| Pain |
0.9% |
| Uterine Haemorrhage |
0.9% |
|
| Unintended Pregnancy |
37.0% |
| Weight Increased |
24.0% |
| Breast Cancer |
5.3% |
| Metrorrhagia |
4.8% |
| Vaginal Haemorrhage |
2.9% |
| Incorrect Dose Administered |
2.4% |
| Injection Site Pain |
2.4% |
| Tremor |
2.4% |
| Menorrhagia |
1.9% |
| Osteopenia |
1.9% |
| Swelling Face |
1.9% |
| Thyroid Cancer |
1.9% |
| Dysphemia |
1.4% |
| Labyrinthitis |
1.4% |
| Osteoporosis |
1.4% |
| Pulmonary Embolism |
1.4% |
| Tachycardia |
1.4% |
| Urticaria |
1.4% |
| Vomiting |
1.4% |
| Amenorrhoea |
1.0% |
|
| Concomitant |
| Depression |
21.9% |
| Crohn's Disease |
12.5% |
| Major Depression |
6.3% |
| Neurilemmoma Malignant |
5.2% |
| Pain |
5.2% |
| Acne Cystic |
4.2% |
| Arthralgia |
4.2% |
| Attention Deficit/hyperactivity Disorder |
4.2% |
| Blood Cholesterol Increased |
4.2% |
| Contraception |
4.2% |
| Diabetes Mellitus |
4.2% |
| Myeloid Leukaemia |
4.2% |
| Bipolar Disorder |
3.1% |
| Convulsion |
3.1% |
| Multiple Sclerosis |
3.1% |
| Acute Myeloid Leukaemia |
2.1% |
| Aggression |
2.1% |
| Alcoholism |
2.1% |
| Amoebic Colitis |
2.1% |
| Pain Management |
2.1% |
|
| Vaginal Haemorrhage |
11.1% |
| Vomiting |
8.9% |
| Weight Increased |
8.9% |
| Hallucination, Visual |
6.7% |
| Pancreatitis |
6.7% |
| Pregnancy |
6.7% |
| Weight Decreased |
6.7% |
| Obesity |
4.4% |
| Osteopenia |
4.4% |
| Pulmonary Embolism |
4.4% |
| Rash |
4.4% |
| Rectal Haemorrhage |
4.4% |
| Viral Infection |
4.4% |
| Vision Blurred |
4.4% |
| Acute Coronary Syndrome |
2.2% |
| Arterial Thrombosis |
2.2% |
| Diabetes Mellitus |
2.2% |
| Drug Ineffective |
2.2% |
| Lung Neoplasm Malignant |
2.2% |
| Metabolic Disorder |
2.2% |
|
| Interacting |
| Contraception |
66.7% |
| Multiple Sclerosis |
33.3% |
|
|
